Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Aficamten by Cytokinetics for Hypertrophic Cardiomyopathy: Likelihood of Approval
Aficamten is under clinical development by Cytokinetics and currently in Pre-Registration for Hypertrophic Cardiomyopathy. According to GlobalData, Pre-Registration drugs for...
CK-4015089 by Cytokinetics for Muscular Dystrophy: Likelihood of Approval
CK-4015089 is under clinical development by Cytokinetics and currently in Phase I for Muscular Dystrophy. According to GlobalData, Phase I...
CK-586 by Cytokinetics for Diastolic Heart Failure (HFpEF): Likelihood of Approval
CK-586 is under clinical development by Cytokinetics and currently in Phase I for Diastolic Heart Failure (HFpEF). According to GlobalData,...